14:06
2026-07-29
letsdatascience.com
artificial-intelligence
FDA Grants Fast Track to Insilico's ISM6331
Insilico Medicine announced on July 29 that the U.S. FDA granted Fast Track Designation to its AI-designed pan-TEAD inhibitor ISM6331 for adults with unresectable malignant pleural mesothelioma after …